Novartis CEO on Q2 earnings beat and patent expiries
Novartis CEO Vas Narasimhan talks with CNBC about the Swiss pharmaceutical company’s second-quarter earnings, forward guidance and patent expiries.
Novartis CEO Vas Narasimhan talks with CNBC about the Swiss pharmaceutical company’s second-quarter earnings, forward guidance and patent expiries.
